KEYMED BIO-B
0216273.1000.21% ( +0.150 )
H2 2025 Earnings
Financial report interval: 2025.07.01 - 2025.12.31
Preview: KEYMED BIO-B(02162) predict that the Revenue is 241.93 M (--%), Miss estimate;the EBIT is -484.42 M (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.24B--
0.38B--
-0.13B--%
EBITMiss expectations
-0.48B--
-0.38B--
-0.11B--%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf